Ziqing (pronunciation: zee ching) is a principal scientist at Bristol Myers Squibb. He received his Ph.D. from Purdue University in Biomedical Engineering. He is the lead of LC Method Screen Best Practice Team in the department of Chemical Process Development. In addition to method screen, he is also working on automation, polymeric impurity monitoring, 2DLC, and other innovative tools for small molecule drug substance analysis.